Design, synthesis and biological evaluation of 2-amino-4-(1,2,4-triazol)pyridine derivatives as potent EGFR inhibitors to overcome TKI-resistance

被引：19
|
作者：
Yang, Haikui [1 ]
Yan, Ruohong [1 ]
Jiang, Ying [1 ]
Yang, Zichao [1 ]
Zhang, Xingmei [2 ]
Zhou, Mingfeng [1 ]
Wu, Xiaoyun [1 ]
Zhang, Tingting [1 ]
Zhang, Jiajie [1 ]
机构：
[1] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China
[2] Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Guangdong Prov Key Lab Psychiat Disorders, Guangzhou 510515, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2020年 / 187卷
基金：
中国国家自然科学基金;
关键词：
EGFR inhibitor; 2-amino-4-(1,2,4-triazol)pyridine; EGFR(T790M); EGFRvIII; TKI-resistance; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; PAN-ERBB INHIBITOR; PHASE-II; BRAIN; MUTATIONS; GEFITINIB; SURVIVAL; AFATINIB; AZD9291;
D O I：
10.1016/j.ejmech.2019.111966
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A new class of 2-amino-4-(1,2,4-triazol)pyridine derivatives were designed and synthesized as potent epidermal growth factor receptor inhibitors. In particular, compound 10c exhibited significant inhibitory against EGFR(L858R/T790M), and also displayed potent anti-proliferative activity against non-small cell lung cancer cell line H1975. Besides, compound 10j showed potent inhibitory activity against glioblastoma cell line U87-EGFRvIII, which was at least 3-fold more potent than Osimertinib and 25-fold superior to Lazertinib. Moreover, molecular modeling and molecular dynamics simulations disclosed the binding model of the most active compound to the domain of EGFR. This contribution provides 2-amino-4-(1,2,4-triazol)pyridines as a new scaffold for EGFR(T790M) and/or EGFRvIII inhibitor. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Design, synthesis and biological evaluation of aminopyrimidine derivatives bearing a 4,5,6,7-tetrahydrothieno [3,2-c]pyridine as potent EGFR inhibitors
    Li, Yingxue
    Chang, Yaoyao
    Fu, Jianfang
    Ding, Rongcai
    Zhang, Lingyun
    Liang, Tian
    Liu, Yajing
    Liu, Yue
    Hu, Jinxing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 226
  • [32] Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors
    Lu, Xiang
    Zhang, Hui
    Li, Xi
    Chen, Guo
    Li, Qing-Shan
    Luo, Yin
    Ruan, Ban-Feng
    Chen, Xian-Wei
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (22) : 6827 - 6832
  • [33] Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors
    Lv, Peng-Cheng
    Zhou, Chang-Fang
    Chen, Jin
    Liu, Peng-Gang
    Wang, Kai-Rui
    Mao, Wen-Jun
    Li, Huan-Qiu
    Yang, Ying
    Xiong, Jing
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (01) : 314 - 319
  • [34] Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors
    Bu, Hong
    Yuan, Xinrui
    Wu, Hanshu
    Zhou, Jinpei
    Zhang, Huibin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 40
  • [35] Design, synthesis and evaluation of derivatives based on pyrimidine scaffold as potent Pan-Raf inhibitors to overcome resistance
    Wang, Lu
    Zhang, Qing
    Zhu, Gaoyuan
    Zhang, Zhimin
    Zhi, Yanle
    Zhang, Li
    Mao, Tianxiao
    Zhou, Xiang
    Chen, Yadong
    Lu, Tao
    Tang, Weifang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 130 : 86 - 106
  • [36] Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine derivatives as potent fibroblast growth factor receptor inhibitors
    Su, Xingping
    Liu, Zhihao
    Yue, Lin
    Wu, Xiuli
    Wei, Wei
    Que, Hanyun
    Ye, Tinghong
    Luo, Yi
    Zhang, Yiwen
    RSC ADVANCES, 2021, 11 (34) : 20651 - 20661
  • [37] Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors
    Li, Chunpu
    Ai, Jing
    Zhang, Dengyou
    Peng, Xia
    Chen, Xi
    Gao, Zhiwei
    Su, Yi
    Zhu, Wei
    Ji, Yinchun
    Chen, Xiaoyan
    Geng, Meiyu
    Liu, Hong
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (05): : 507 - 512
  • [38] 2-Amino-4-(ferrocenyl)-5-(1H-1,2,4-triazol-1-yl)-1,3-thiazole
    Shao, L
    Hu, Y
    Zhou, X
    Zhang, Q
    Fang, JX
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2005, 61 : M1269 - M1271
  • [39] Design, synthesis and biological evaluation of 2,3-dihydro-[1,4]dioxino [2,3-f]quinazoline derivatives as EGFR inhibitors
    Qin, Xuemei
    Yang, Leifu
    Liu, Peng
    Yang, Lifang
    Chen, Linmeng
    Hu, Liming
    Jiang, Mingguo
    BIOORGANIC CHEMISTRY, 2021, 110
  • [40] Design, synthesis and biological evaluation of 2-aminopyrimidine derivatives as potent FLT3 inhibitors
    Lian, Xuanmin
    Gao, Yue
    Li, Xuemei
    Wang, Peipei
    Tong, Lexian
    Li, Jia
    Zhou, Yubo
    Liu, Tao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 96
12345